Home › Polycythemia Vera
Polycythemia Vera clinical trials recruiting in the U.S.
16 studies for Polycythemia Vera are recruiting participants at sites across the United States.
Cities with the most studies
- Durham, NC5 studies
- New York City, NY5 studies
- Columbus, OH3 studies
- Miami, FL3 studies
- Coral Springs, FL3 studies
- Irvine, CA3 studies
- Tampa, FL3 studies
- Houston, TX3 studies
- Salt Lake City, UT3 studies
By state
- California5 studies
- Florida4 studies
- Maryland3 studies
- Michigan3 studies
- New York6 studies
- North Carolina6 studies
- Ohio5 studies
- Pennsylvania4 studies
- Texas3 studies
- Utah3 studies
Recently updated studies
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT06661915A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07469891Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT04282187INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT07429266Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT07441694Registry of Older Patients With Cancer
RecruitingObservational study
Ages 65 and older · All sexes · Updated Jun 29, 2026 · NCT01137825A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Apr 2, 2026 · NCT06351631Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 27, 2026 · NCT06063486Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Mar 25, 2026 · NCT06093672An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Mar 10, 2026 · NCT05123365MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 23, 2026 · NCT07362225Ruxolitinib in Thrombocythemia and Polycythemia Vera
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jan 8, 2026 · NCT04644211MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 17, 2025 · NCT06541249Two Step Haplo With Radiation Conditioning
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 30, 2025 · NCT05031897Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Oct 27, 2025 · NCT01137643Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition
RecruitingPhase 1
Ages 18 and older · All sexes · Updated May 3, 2024 · NCT06218628From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.